A Successful Kidney Transplant in a Patient With Hemophilia C.

Hemophilia C is a rare bleeding disorder, and such patients with chronic kidney disease are at risk for bleeding during kidney transplant surgery. Kidney transplant patients with hemophilia C can be managed meticulously through a protocol to maintain a coagulation profile in the reference range. Here, we present a case study that focused on a treatment protocol for a patient with chronic kidney disease and hemophilia C who underwent kidney transplant surgery.

Marked erythrocytosis during treatment with sodium glucose cotransporter-2 inhibitors-report of two cases.

SGLT-2 inhibitors are known to increase hematocrit. We present two cases with marked asymptomatic erythrocytosis developing after taking SGLT-2 inhibitors. No other predisposing or causative factor was found and SGLT-2 inhibitor drug was the most likely cause in both cases.

Osteoporosis in young haemophiliacs from western India.

Arthropathies and joint deformities in patients with severe hemophilia result in prolonged immobilization, reduced physical activity, and predispose them for osteoporosis. This can lead to an increasing tendency of bone fragility and fractures in patients after trivial trauma. The aim of this study was to find out (i) the prevalence of osteoporosis in hemophilia patients and (ii) the association of osteoporosis with hemophilic arthropathy and related restricted physical activity.